Executive Summary
The sole contract in this digest is a $237.8 million firm-fixed-price award to M. A. Mortenson Company by the National Institutes of Health (NIH) for design-build construction of a clinical and computational science building in Bethesda, MD. This is a civilian, non-defense award, representing a fully funded, multi-year revenue stream with no options or set-asides.
The highest-conviction signal is the full upfront funding and competitive award, indicating strong execution confidence from NIH. A key risk is the firm-fixed-price structure, which transfers cost overrun risk to Mortenson, particularly given the specialized research facility requirements.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal Construction & Infrastructure Contracts digest from September 16, 2026.
Investment Signals (1)
- M. A. Mortenson Company Wins $237.8M NIH Construction Contract (HIGH)▲
Mortenson secured a $237.8 million firm-fixed-price delivery order for design-build construction of a clinical and computational science building at NIH, with full funding upfront and a ~4.3-year performance period (Dec 2026 – Mar 2031). This provides a low-risk, multi-year revenue stream of approximately $55.3 million annually.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
The firm-fixed-price structure of the $237.8M NIH contract transfers all cost overrun risk to Mortenson, which is elevated for specialized research facility construction (NAICS 236220). Any design or construction challenges could compress margins.
- Concentration [LOW RISK]▼
This digest contains only one contract, all awarded to M. A. Mortenson Company, creating a complete concentration risk for this analysis period. No diversification across contractors or agencies is present.
Opportunities (1)
- ◆
The $237.8M NIH award signals sustained federal investment in biomedical research infrastructure. Investors should watch for follow-on NIH construction contracts or task orders under existing IDIQs that could benefit Mortenson or other large commercial builders.
Sector Themes (1)
- ◆
The $237.8M NIH award to Mortenson underscores a federal push to modernize biomedical research facilities, driven by NIH's mission to expand computational and clinical science capabilities. This is a civilian-sector theme, distinct from defense construction.
Watch List (2)
- 👁
{"entity" => "M. A. Mortenson Company", "reason" => "This $237.8M contract represents a significant, multi-year revenue stream. Execution on this specialized facility will be a key indicator of project management capability.", "trigger" => "Q1 2027 earnings call for initial revenue recognition; any change order announcements"}
- 👁
{"entity" => "National Institutes of Health (NIH)", "reason" => "As the sole awarding agency, NIH's future construction budget and procurement patterns will determine follow-on opportunities for Mortenson and competitors.", "trigger" => "FY2028 NIH budget request; any new solicitations for research facility construction"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal Construction & Infrastructure Contracts
September 13, 2026
Federal Construction & Infrastructure Contracts — September 13, 2026
September 12, 2026
Federal Construction & Infrastructure Contracts — September 12, 2026
September 11, 2026
Federal Construction & Infrastructure Contracts — September 11, 2026
September 10, 2026
Federal Construction & Infrastructure Contracts — September 10, 2026
🇺🇸 More from United States
View all →September 17, 2026
US Merger & Acquisition SEC Filings — September 17, 2026
US Merger & Acquisition SEC Filings
September 17, 2026
US Corporate Board Director Changes SEC Filings — September 17, 2026
US Corporate Board Director Changes SEC Filings
September 17, 2026
US Executive Officer Management Changes SEC — September 17, 2026
US Executive Officer Management Changes SEC
September 17, 2026
US IPO Pipeline SEC S-1 Filings — September 17, 2026
US IPO Pipeline SEC S-1 Filings